# Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/once-weekly-albiglutide-versus-once-daily-liraglutide-in-patients-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard E. Pratley,Michael A. Nauck,Anthony Barnett,Mark N. Feinglos,Fernando Ovalle,Illana Harman-Boehm,June Ye,Rhona Scott,Susan Johnson,Murray Stewart,Julio Rosenstock |
| Citations | 326 |
| DOI | 10.1016/s2213-8587(13)70214-6 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2128825255 |
| PMID | 24703047 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Richard E. Pratley](https://scholariq.org/researchers/richard-e-pratley/)
- [Murray Stewart](https://scholariq.org/researchers/murray-stewart/)
- [Julio Rosenstock](https://scholariq.org/researchers/julio-rosenstock/)

## Paper journal

- [The Lancet Diabetes & Endocrinology](https://scholariq.org/journals/the-lancet-diabetes-and-endocrinology/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.